glp 1 drugs and ulcerative colitis Glucagon-like peptide-1 (GLP-1) receptor agonists in inflammatory bowel disease: mechanisms, clinical implications, therapeutic potential GLP-1 Receptor Agonists in Obese
Description
Daniel McGee, Board-certified Family Medicine Physician When Discomfort Becomes a Danger Zone While many of the GI side effects we discussed above are common, some more adverse effects are not and could have serious complications
Neurogastroenterol Motil 2017;29
10.1111/obr.12334 4
Almost three decades ago, the discovery of leptin triggered a new era of molecular obesity research
